Life Sciences

Views & Analysis

At ESMO 2022, oncologists saw exciting cancer advances

Lung, breast, and non-prostate genitourinary (NGU) cancer treatments were the most exciting tracks due to the march towards personalised medicine and expanded immunotherapy options.

Patients

Live from Reuters Pharma 2022 - the pharmaphorum podcast

In mid-October, our Web Editor Nicole Raleigh and Deep Dive Editor Eloise McLennan travelled to Nice for the Reuters Pharma event.

News

group of chemical scientists working at the laboratory.

BMA responds to ABPI report, warns UK losing research leader...

In response to the recent Association of British Pharmaceutical Industry (ABPI) report, which showed a sharp decline (41%) in clinical trials initiated by the UK in the period 2017 to 2021,

Views & Analysis

The criticality of compliance

Remaining compliant is imperative to the life sciences industry, so adhering to regulatory requirements is mandatory.

News

Verily raises $1bn to push ahead with precision health plans

It's all change at Alphabet's life sciences business Verily, with a $1 billion funding round and a shake-up of its senior leadership, including a new chief executive and executive chairman,

Market Access